0001127602-13-002179.txt : 20130117
0001127602-13-002179.hdr.sgml : 20130117
20130117164439
ACCESSION NUMBER: 0001127602-13-002179
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130115
FILED AS OF DATE: 20130117
DATE AS OF CHANGE: 20130117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CLACKSON TIMOTHY P
CENTRAL INDEX KEY: 0001242992
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21696
FILM NUMBER: 13535283
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS INC
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884731
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 223106987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174940400
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2013-01-15
0000884731
ARIAD PHARMACEUTICALS INC
ARIA
0001242992
CLACKSON TIMOTHY P
C/O ARIAD PHARMACEUTICALS INC
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
1
President, R&D, CSO
Common Stock
2013-01-15
4
M
0
4766
5.23
A
288037
D
Common Stock
2013-01-15
4
M
0
44542
4.49
A
332579
D
Common Stock
2013-01-15
4
M
0
8631
7.82
A
341210
D
Employee Stock Option (Right to Buy)
5.23
2013-01-15
4
M
0
4766
0
D
2006-09-09
2014-09-09
Common Stock
4766
0
D
Employee Stock Option (Right to Buy)
4.49
2013-01-15
4
M
0
44542
0
D
2008-04-16
2017-04-16
Common Stock
44542
0
D
Employee Stock Option (Right to Buy)
7.82
2013-01-15
4
M
0
8631
0
D
2012-04-01
2021-04-01
Common Stock
8631
17262
D
Shares were aquired upon the exercise of outstanding stock options at $5.23 per share.
Shares were aquired upon the exercise of outstanding stock options at $4.49 per share.
Shares were aquired upon the exercise of outstanding stock options at $7.82 per share.
/s/Edward M. Fitzgerald, Attorney-in-Fact
2013-01-17